On the possible pharmacological role of UDP-glucose on some muscular metabolites

Farmaco Sci. 1984 Mar;39(3):246-54.

Abstract

The effects of intraperitoneal administration of UDP-glucose were studied on male rat gastrocnemius muscle. Muscular glycolytic substrates and metabolites (glycogen, glucose, glucose-6-phosphate, pyruvate, lactate), Krebs' cycle intermediates (citrate, alpha-ketoglutarate, malate), related aminoacids (glutamate, alanine), ammonia, energy store and mediators (creatine phosphate, ATP, ADP, AMP) and the energy charge potential were evaluated. UDP-glucose was administered intraperitoneally at doses of 0.8, 2.0 and 5.0 mg/kg daily for 1, 2 and 4 weeks. The influence of the factors: "dose" of UDP-glucose and "time-course" of treatment was defined. After two weeks, the administration of the three doses tested of UDP-glucose changed the muscular concentration of few glycolytic metabolites, and of some Krebs' cycle intermediates, while after 1 or 4 weeks of treatment there was negligible response.

MeSH terms

  • Anaerobiosis
  • Animals
  • Energy Metabolism / drug effects
  • Glycolysis / drug effects
  • Hydrolysis
  • Male
  • Muscles / drug effects
  • Muscles / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • Uridine Diphosphate Glucose / pharmacology
  • Uridine Diphosphate Glucose / physiology*
  • Uridine Diphosphate Sugars / physiology*

Substances

  • Uridine Diphosphate Sugars
  • Uridine Diphosphate Glucose